Last reviewed · How we verify

NCT06191666

BfedBwell Proof-of-Concept Pilot

Completed NA Last updated 11 February 2026
What this trial tests

NA trial testing Group-based education and discussion in Cancer Survivorship in 20 participants. Completed in 16 December 2024.

Timeline
5 February 2024
Primary endpoint
16 December 2024
16 December 2024

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment20
Start date5 February 2024
Primary completion16 December 2024
Estimated completion16 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 18 to 75, any sex, with Cancer Survivorship or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-arm proof-of-concept pilot will assess the feasibility and acceptability of integrating a survivorship nutrition intervention (BfedBwell) into an existing clinical exercise oncology program (BfitBwell).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer Survivorship

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06191666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing